Newsfiscal.ai
Needham Maintains Buy Rating and $44.00 Price Target on Lyell Immunopharma
· Published
Article summary
Needham has reaffirmed its 'Buy' rating and $44.00 price target for Lyell Immunopharma, Inc. shares.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…


Comments —
Loading comments…